Restatement of Prior Period (Details 3) - USD ($)	3 Months Ended	6 Months Ended		12 Months Ended
	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Bank overdraft		$ 0	$ (163,400)	$ (321,700)	$ 278,600
Net cash received in financing activities		0	(163,400)	2,306,700	16,588,800
Effect of changes in foreign currency exchange rates on cash and cash equivalents		1,500	103,000	(71,300)	(9,200)
Net (decrease) increase in cash and cash equivalents		(1,044,000)	(5,378,200)	(6,704,100)	2,115,500
Cash and cash equivalents, beginning of period	$ 2,971,100	2,971,100	9,675,200	9,675,200	7,559,700
Cash and cash equivalents, end of period		1,927,100	4,297,000	2,971,100	9,675,200
Income taxes		0	0	0	2,500
Record right-of-use assets		104,326	0	1,010,900	0
Record lease liabilities		104,642	0	1,010,400	0
Income (Loss) from Operations		(4,079,400)	(2,105,300)	(13,668,100)	(3,672,500)
Extinguishment of debt		0	(433,800)	(433,800)	(531,000)
Depreciation and amortization		380,800	327,300	688,200	251,500
Stock-based compensation costs		1,236,700	1,266,400	2,350,600	2,108,000
Loss/(Gain) on sale of investment securities		89,200	(4,000)	32,700	(35,600)
Unrealized holding (gain)/loss on investment securities		(18,900)	32,600	233,700	10,400
Change in fair value of contingent consideration		0	(60,000)	(42,500)	(30,000)
Deferred income taxes		0	(733,300)	2,490,000	(1,152,500)
Loss on disposal of subsidiary		0	0	0	405,400
Trade accounts receivable		175,600	(50,100)	(206,700)	(75,500)
Inventories		(733,600)	(637,900)	(1,719,200)	(560,000)
Prepaid and other current assets		89,400	(229,700)	(207,800)	(211,400)
Income tax receivable		(300)	267,300	172,200	1,500
Carrying value of right of use assets		103,800	(1,600)	(810,200)	138,000
Accounts payable		(191,500)	461,300	652,400	79,600
Contract liabilities		106,500	0	29,000	(20,000)
Lease Liabilities		0	(10,900)	807,900	(105,600)
Other assets		4,200	(8,200)	(8,100)	0
Other long term liabilities		(107,600)	0	(10,900)	10,900
Accrued expenses and taxes		27,300	(11,100)	180,300	(195,300)
Total adjustments		(526,200)	(220,900)	(1,121,100)	(937,800)
Net cash used in operating activities		(2,849,000)	(1,931,000)	(5,190,200)	(3,580,100)
Redemption of investment securities		2,404,200	844,300	2,709,800	6,181,400
Purchase of investment securities		(346,200)	(4,001,200)	(5,634,500)	(9,569,000)
Proceeds from sale of Altamira		0	0	0	440,000
Purchase of Aquila, net of cash acquired		0	0	0	(7,679,000)
Capital expenditures		(253,000)	(163,400)	(757,600)	(198,700)
Purchase of other intangible assets		(1,500)	(66,500)	(67,000)	(58,700)
Net cash provided by (used) in investing activities		1,803,500	(3,386,800)	(3,749,300)	(10,884,000)
Proceeds from issuance of common stock		0	0	3,000,000	17,080,400
Issuance of common stock and warrants		0	0	(272,800)	(1,006,400)
Payments of contingent consideration		0	0	(98,800)	(168,000)
Goodwill impairment charge		51,500	0	4,280,100	0
Proceeds from Payroll Protection Program, net of repayment		0	0	0	401,100
Proceeds from stock options exercised		0	0	0	3,100
Provision for bad debt		17,300	0	0	4,000
Effect of Restatement [Member]
Net (decrease) increase in cash and cash equivalents	0
Income (Loss) from Operations	(417,200)			(8,023,700)
Deferred income taxes	(417,200)			(3,743,600)
Total adjustments				0
Net cash used in operating activities	0			0
Net cash provided by (used) in investing activities	0
Goodwill impairment charge				4,280,100
As Filed [Member]
Bank overdraft	84,000			(321,700)
Net cash received in financing activities	84,000			2,306,700
Effect of changes in foreign currency exchange rates on cash and cash equivalents	(17,700)			(71,300)
Net (decrease) increase in cash and cash equivalents	(533,400)			(6,704,100)
Cash and cash equivalents, beginning of period	2,971,100	2,971,100	9,675,200	9,675,200
Cash and cash equivalents, end of period	2,437,700			2,971,100	9,675,200
Income taxes				0
Record right-of-use assets	41,100			1,010,900
Record lease liabilities	38,800			1,010,400
Income (Loss) from Operations	(1,292,000)			(5,644,400)
Extinguishment of debt				(433,800)
Depreciation and amortization	188,900			688,200
Stock-based compensation costs	618,100			2,350,600
Loss/(Gain) on sale of investment securities	56,900			32,700
Unrealized holding (gain)/loss on investment securities	12,100			233,700
Change in fair value of contingent consideration				(42,500)
Deferred income taxes	(417,200)			1,253,600
Loss on disposal of subsidiary				0
Trade accounts receivable	391,200			(206,700)
Inventories	(334,100)			(1,719,200)
Prepaid and other current assets	26,400			(207,800)
Income tax receivable	(300)			172,200
Carrying value of right of use assets				(810,200)
Accounts payable	(674,800)			652,400
Contract liabilities				29,000
Contingent Consideration				0
Lease Liabilities	(32,200)			807,900
Other assets				(8,100)
Discontinued operations				17,800
Other long term liabilities	0			(10,900)
Accrued expenses and taxes	(11,100)			180,300
Total adjustments				(454,200)
Net cash used in operating activities	(1,466,300)			(5,190,200)
Redemption of investment securities	1,043,000			2,709,800
Purchase of investment securities	14,800			5,634,500
Proceeds from sale of Altamira				0
Purchase of Aquila, net of cash acquired				0
Capital expenditures	(160,100)			(757,600)
Purchase of other intangible assets	(1,500)			(67,000)
Net cash provided by (used) in investing activities	866,600			(3,749,300)
Proceeds from issuance of common stock				3,000,000
Issuance of common stock and warrants				(272,800)
Payments of contingent consideration				(98,800)
Goodwill impairment charge				0
Deferred revenue	(27,900)			0
As Restated [Member]
Bank overdraft	84,000			(321,700)
Net cash received in financing activities	84,000			2,306,700
Effect of changes in foreign currency exchange rates on cash and cash equivalents	(17,700)			(71,300)
Net (decrease) increase in cash and cash equivalents	(533,400)			(6,704,100)
Cash and cash equivalents, beginning of period	2,971,100	$ 2,971,100	$ 9,675,200	9,675,200
Cash and cash equivalents, end of period	2,437,700			2,971,100	$ 9,675,200
Income taxes				0
Record right-of-use assets	41,100			1,010,900
Record lease liabilities	38,800			1,010,400
Income (Loss) from Operations	(1,709,200)			(13,668,100)
Extinguishment of debt				(433,800)
Depreciation and amortization	188,900			688,200
Stock-based compensation costs	618,100			2,350,600
Loss/(Gain) on sale of investment securities	56,900			32,700
Unrealized holding (gain)/loss on investment securities	12,100			233,700
Change in fair value of contingent consideration				(42,500)
Deferred income taxes	0			2,490,000
Loss on disposal of subsidiary				0
Trade accounts receivable	391,200			(206,700)
Inventories	(334,100)			(1,719,200)
Prepaid and other current assets	26,400			(207,800)
Income tax receivable	(300)			172,200
Carrying value of right of use assets				(810,200)
Accounts payable	(674,800)			652,400
Contract liabilities				29,000
Contingent Consideration				0
Lease Liabilities	(32,200)			807,900
Other assets				(8,100)
Discontinued operations				17,800
Other long term liabilities	0			(10,900)
Accrued expenses and taxes	(11,100)			180,300
Total adjustments				(8,477,900)
Net cash used in operating activities	(1,466,300)			(5,190,200)
Redemption of investment securities	1,043,000			2,709,800
Purchase of investment securities	14,800			5,634,500
Proceeds from sale of Altamira				0
Purchase of Aquila, net of cash acquired				0
Capital expenditures	(160,100)			(757,600)
Purchase of other intangible assets	(1,500)			(67,000)
Net cash provided by (used) in investing activities	866,600			(3,749,300)
Proceeds from issuance of common stock				3,000,000
Issuance of common stock and warrants				(272,800)
Payments of contingent consideration				(98,800)
Goodwill impairment charge				4,280,100
Deferred revenue	$ (27,900)			0
Provision for bad debt				$ 0